History Hikayemiz

Our Story

1942
1942

Founded in 1942, Eczacıbaşı is a prominent Turkish industrial group. Eczacıbaşı’s core sectors are building products, consumer products and healthcare.

1952
1952

In 1950, Dr. Nejat F. Eczacıbaşı applies for a credit from the Industrial Development Bank of Turkey, newly established to provide credit to private sector investments in industry. He hopes to expand his small pharmaceutical operation employing 10 people in five rooms of the Aya Andrea business center in Galata, Istanbul, into a pharmaceutical plant. Dr. Nejat F. Eczacıbaşı passes the examination of the credit committee and begins preparing for the construction of a modern pharmaceutical plant in Levent.
In 1952, Eczacıbaşı inaugurates Eczacıbaşı Pharmaceuticals Manufacturing, Turkey’s first modern pharmaceutical plant.

1989
1989

Eczacıbaşı Pharmaceuticals Marketing (EPM/EIP) was established. The sales and marketing activities of Eczacıbaşı Pharmaceuticals Industry have been carried out by EPM since this year.

1992
1992

Eczacıbaşı's 50th anniversary became the beginning of a new period of growth for the Group with five new investments.
The modern pharmaceutical complex of Eczacıbaşı Pharmaceuticals Industry in Lüleburgaz started production with an annual production capacity of 150 million units.

1993
1993

Dr. Nejat F. Eczacıbaşı, founder of the Group and Honorary Chairman of the Board of Eczacıbaşı Holding, passes away. Şakir Eczacıbaşı becomes Chairman of the Board.

2007
2007

Eczacıbaşı Pharmaceuticals Industry transferred 75% of its shares in Eczacıbaşı Health Products and Eczacıbaşı Özgün Kimya to Zentiva N.V., one of the leading generic drug companies in Europe.

2009
2009

All shares of Eczacıbaşı Group in Eczacıbaşı-Zentiva Health Products and Eczacıbaşı-Zentiva Chemical Products were transferred to Zentiva N.V.. Eczacıbaşı Pharmaceuticals Marketing's Vicks brand was awarded with the grand prize in two categories by FARMASKOP AWARDS which rewards the innovative communication in the health sector.
 

2011
2011

It collaborated with Juvisé Pharmaceuticals, a rising star in the pharmaceutical industry of France, in the field of psychiatric medicine. The first step of the collaboration was the licensing agreement of an antidepressant used for the treatment of mental disorders accompanied by the conditions such as anxiety, restlessness, lack of concentration and especially psychosomatic disorders.

2014
2014

P&G (Procter & Gamble), one of the leading companies in the fast-moving consumer goods sector, signed an important collaboration with Eczacıbaşı Pharmaceuticals Marketing within the scope of its growth target in the healthcare group. With this collaboration, P&G aims to offer its products to more pharmacy consumers.

2015
2015

Aon Best Employers “Employee Engagement Success Award”

2016
2016

Following the restructuring of Baxter's biotechnological innovative products division under a new company called Baxalta, Eczacıbaşı-Baxter's Hospital Products and Biosurgery Departments joined Eczacıbaşı Pharmaceuticals Marketing. Thus, EPM became an organization that covers all the service areas in the health sector.

2016
2016

Aon Best Employers “Best Places to Work Award”

2016
2016

Brandon Hall “Best Results of a Learning Program” Golden Award “Make a Difference With Your Presence Project”

2017
2017

International LEAD Awards, Best Results of a Learning Programme “Make a Difference With Your Presence Project”

2017
2017

Turkey Reputation Index “Reputable Company Award” in the pharma industry

2018
2018

GPTW Turkey Reputation Index “Reputable Company Award” in the pharma industry

2019
2019

Turkey Reputation Index “Reputable Company Award” in the pharma industry

2019
2019

The winner brands of their sector were announced at Good Life Brands that was held for the second time this year by Nielsen for Sustainable Brands Istanbul - a group of global brands - and is focused on the life style and consumption habits of Turkish consumers.
Under the Healthcare category where the question «Which company tries to help most for enabling the consumers accessing to better life?» was asked, Eczacıbaşı Pharmaceutical Marketing ranked as first and granted with «Good Life Brand» award.

2019
2019

Novartis and Eczacibasi have signed a cooperation agreement regarding the sale, promotion and distribution of 3 cancer treatment drugs, the licenses of which are owned by Novartis. As per the agreement, Eczacibasi shall be granted the right to sell, promote and distribute such drugs in Turkey starting from 1 August 2019.

2019
2019

Eczacıbaşı Pharmaceuticals Marketing has received the silver excellence in the Succession and Career Management category at the Talent Management Awards, given by Brandon Hall Group, one of the world’s most prestegious consulting companies, with ‘’Color of Presence’’ training programme that was created in 2019 to contribute to the development journeys of field employees.

2020
2020

Eczacıbaşı Pharmaceuticals Marketing won the award in the 250-500 employee number category of best employers of Turkey 2020 survey carried out by Great Place to Work Institute.